Long-term ACE inhibition in Alport syndrome: are the benefits worth the risks?
Sign Up to like & getrecommendations! Published in 2020 at "Kidney international"
DOI: 10.1016/j.kint.2020.01.030
Abstract: Gross et al. present results of the EARLY PRO-TECT trial, a randomized controlled trial of ramipril versus placebo in children with early-stage Alport syndrome. Although under-enrolled and not a positive trial in the traditional sense, EARLY… read more here.
Keywords: long term; ace inhibition; inhibition alport; alport syndrome ... See more keywords